Due to the dependance of the JAK/STAT signaling pathway in ALCL we hypothesized AC-4-140 would be an attractive therapeutic strategy in our PDGFRβ+ ALCL model. The gene discussed is PDGFRB; the disease is anaplastic large cell lymphoma.